A meta-analysis by Tornesello et al. (59) which included 1,353 cervical tumors found that non-synonymous mutations in the DNA-binding domain of TP53 were found in 13.3% for adenocarcinoma and 5.9% in squamous cell carcinoma (59). This evidence concerns the gene TP53 and uterine cervix neoplasm.